Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Fate Therapeutics Inc banner

Fate Therapeutics Inc
SWB:F6T

Watchlist Manager
Fate Therapeutics Inc Logo
Fate Therapeutics Inc
SWB:F6T
Watchlist
Price: 2.172 EUR -6.7% Market Closed
Market Cap: €2.6B
Write Note Create Alert Ask AI

Wall St Price Targets

F6T Price Targets Summary
Fate Therapeutics Inc

Wall Street analysts forecast F6T stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for F6T is 4.758 EUR with a low forecast of 1.898 EUR and a high forecast of 7.174 EUR.

F6T Lowest Forecast
Wall Street Target
€1.898
-13% Downside
F6T Average Forecast
Wall Street Target
€4.758
119% Upside
F6T Highest Forecast
Wall Street Target
€7.174
230% Upside
Lowest Forecast
Price Target
1.898 EUR
13% Downside
Average Forecast
Price Target
4.758 EUR
119% Upside
Highest Forecast
Price Target
7.174 EUR
230% Upside
Fate Therapeutics Inc Competitors:
Price Targets
B
BRI
Britania PCL
12% Upside
MRVL
Marvell Technology Group Ltd
24% Upside
AYTU
Aytu Biopharma Inc
324% Upside
B
BRI
Britania PCL
12% Upside
MRVL
Marvell Technology Group Ltd
24% Upside
AYTU
Aytu Biopharma Inc
324% Upside

Revenue
Forecast

7% / Year
Past Growth
70% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
7% / Year
Past Growth
70% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 8 years is 70%.

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

What are analyst estimates?

Continue F6T Research

Summary
F6T intrinsic value, competitors valuation, and company profile.
DCF Valuation
F6T stock valuation using Discount Cash Flow valuation method.
Relative Valuation
F6T stock valuation using valuation multiples.
Wall St Estimates
F6T price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
F6T stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Fate Therapeutics Inc listings:
NASDAQ • USD
FATE
 F • EUR
F6T
 XBER • EUR
F6T
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is F6T's stock price target?
Price Target
4.758 EUR

According to Wall Street analysts, the average 1-year price target for F6T is 4.758 EUR with a low forecast of 1.898 EUR and a high forecast of 7.174 EUR.

What is the Revenue forecast for Fate Therapeutics Inc?
Projected CAGR
70%

Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 8 years is 70%.

Back to Top
ALPHA SPREAD
Follow us
Join 355,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett